TwinBeech Capital’s Hims & Hers Health HIMS Stock Holding History

TwinBeech Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-308,712	Closed	-$5.69M	–	744
2024 Q3	$5.69M	Buy	308,712 +111,868	+57%	+$2M	0.11%	218
2024 Q2	$3.97M	Buy	+196,844	New	+$3.28M	0.08%	254
2024 Q1	–	Sell	-278,440	Closed	-$2.48M	–	697
2023 Q4	$2.48M	Buy	278,440 +60,622	+28%	+$448K	0.04%	369
2023 Q3	$1.37M	Buy	+217,818	New	+$1.62M	0.03%	452
2023 Q2	–	Sell	-95,147	Closed	-$944K	–	713
2023 Q1	$944K	Buy	+95,147	New	+$834K	0.02%	460
2022 Q4	–	Sell	-221,571	Closed	-$1.24M	–	786
2022 Q3	$1.24M	Sell	221,571 -18,587	-8%	-$112K	0.03%	417
2022 Q2	$1.09M	Buy	240,158 +85,890	+56%	+$366K	0.05%	313
2022 Q1	$822K	Buy	154,268 +96,901	+169%	+$479K	0.04%	341
2021 Q4	$376K	Buy	+57,367	New	+$415K	0.02%	451
2021 Q3	–	Sell	-48,420	Closed	-$527K	–	663
2021 Q2	$527K	Buy	+48,420	New	+$576K	0.06%	298

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TwinBeech Capital's HIMS Position: Q4 2024 in Review

TwinBeech Capital sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 308,712 shares — an estimated $5.69M sold.

TwinBeech Capital first reported a position in HIMS in Q2 2021 and held it in 10 quarters. The position peaked at $5.69M in Q3 2024. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

TwinBeech Capital reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
TwinBeech Capital sold 308,712 Hims & Hers Health shares in Q4 2024, an estimated $5.69M.
TwinBeech Capital first reported a position in Hims & Hers Health in Q2 2021 and held it in 10 quarters.
TwinBeech Capital's Hims & Hers Health position peaked at $5.69M in Q3 2024.
394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.